GDRX - Goodrx Holdings  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GDRX is currently covered by 23 analysts with an average price target of $7.45. This is a potential upside of $3.62 (94.52%) from yesterday's end of day stock price of $3.83.

Goodrx Holdings 's activity chart (see below) currently has 189 price targets and 183 ratings on display. The stock rating distribution of GDRX is 62.69% HOLD, 34.33% BUY and 2.99% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.27% with an average time for these price targets to be met of 71.11 days.

Highest price target for GDRX is $7, Lowest price target is $5, average price target is $7.55.

Most recent stock forecast was given by KEVIN CALIENDO from UBS on 13-May-2025. First documented stock forecast 19-Oct-2020.

Currently out of the existing stock ratings of GDRX, 42 are a HOLD (62.69%), 23 are a BUY (34.33%), 2 are a SELL (2.99%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5.25

$1.51 (40.37%)

$6

14 days ago
(13-May-2025)

1/3 (33.33%)

$0.95 (22.09%)

75

Hold

$5

$1.26 (33.69%)

$8.5

18 days ago
(09-May-2025)

9/14 (64.29%)

$0.68 (15.74%)

104

Buy

$7

$3.26 (87.17%)

$8

28 days ago
(29-Apr-2025)

5/9 (55.56%)

$2.34 (50.21%)

99

Hold

$5.5

$1.76 (47.06%)

$6.5

1 months 17 days ago
(10-Apr-2025)

8/17 (47.06%)

$1.18 (27.31%)

34

Buy

$6.25

$2.51 (67.11%)

$7

4 months 17 days ago
(10-Jan-2025)

4/8 (50%)

$1.7 (37.36%)

124

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GDRX (Goodrx Holdings ) average time for price targets to be met?

On average it took 71.11 days on average for the stock forecasts to be realized with a an average price target met ratio 47.27

Which analyst has the current highest performing score on GDRX (Goodrx Holdings ) with a proven track record?

CHARLES RHYEE

Which analyst has the most public recommendations on GDRX (Goodrx Holdings )?

Charles Rhyee works at LAKE STREET and has 28 price targets and 16 ratings on GDRX

Which analyst is the currently most bullish on GDRX (Goodrx Holdings )?

Nathan Jones with highest potential upside - $47.51

Which analyst is the currently most reserved on GDRX (Goodrx Holdings )?

Aaron Kessler with lowest potential downside - -$0

Goodrx Holdings  in the News

GoodRx Holdings Inc (GDRX) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic ...

Total Revenue: $203 million, up 3% year-over-year. Prescription Transactions Revenue: Increased by 2% year-over-year. Manufacturer Solutions Revenue: Increased by 17% year-over-year. Adjusted EBITDA: $69.8 million, up 11% year-over-year. Adjusted EBITDA Margin: 34.4%, an improvement of 60 basis points from the previous quarter. Cash and Liquidity: $301 million in cash and $91.7 million unused capacity on...

Q1 2025 GoodRx Holdings Inc Earnings Call

Participants Aubrey Reynolds; Director of Investor Relations; GoodRx Holdings Inc Wendy Barnes; Chief Executive Officer; GoodRx Holdings Inc Christopher McGinnis; Chief Financial Officer; GoodRx Holdings Inc Lisa Gill; Analyst; JPMorgan John Ransom; Analyst; Raymond James Charles Rhyee; Analyst; TD Cowen Jailendra Singh; Analyst; Truist Securities Craig Hettenbach; Analyst; Morgan Stanley George Hill; Analyst; Deutsche Bank...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?